TY  - GEN
AU  - Mawatari,T
AU  - Muraoka,R
AU  - Iwamoto,Y
TI  - Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials
SN  - 1433-2965
PY  - 2018///0703
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - therapeutic use
KW  - Clinical Trials, Phase III as Topic
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Lumbar Vertebrae
KW  - physiopathology
KW  - Male
KW  - Middle Aged
KW  - Osteoporosis
KW  - blood
KW  - Osteoporotic Fractures
KW  - etiology
KW  - Randomized Controlled Trials as Topic
KW  - Risedronic Acid
KW  - Spinal Fractures
KW  - Vitamin D
KW  - analogs & derivatives
KW  - Vitamin D Deficiency
N1  - Publication Type: Journal Article; Meta-Analysis
UR  - https://doi.org/10.1007/s00198-016-3848-4
ER  -